SensiGen’s medical research translates into new jobs, plans to hire three

The SensiGen start-up is making moves in Ann Arbor, hiring two ex-Pfizer employees with its sights on hiring more.

Many young companies don’t survive the death of a co-founder, but SensiGen in Ann Arbor is doing just the opposite of that conventional wisdom.

The University of Michigan spin-off has grown to seven employees and four contractors from the original two founders in the last four years. There are three job openings right now. Those new workers include two ex-Pfizer employees and the firm expects to hire more as soon as it closes its latest round of capital fundraising.

“We’re very likely to hire more when we secure financing,” says Jay Stoerker, vice president of product development for SensiGen.

This is after U-M Prof. in Pediatrics David Kurnit died in January, leaving his wife and co-founder Kris Kurnit behind to steer the molecular diagnostics company. The firm specializes in developing a test for the human papilloma virus. SensiGen is also developing a test for chronic kidney disease.

Source: Jay Stoerker, vice president of product development for SensiGen
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

We want to know what's on your mind.

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.